food drug administration banned imports plant operated mumbaibased sun pharmaceutical industries ltd amid widening scrutiny indian drugmakers feed 93 billion us generics market
sun pharma facility gujarat state put fdas red list meaning products detained without physical examination according posting fda website company indias largest drugmaker market value plunged almost two years mumbai trading
curbs another blow indias generics industry sells drugs ingredients worldwide january fda placed ban products plant run sun pharma rival ranbaxy laboratories ltd
fda definitely becoming stringent streamline system said surya patra analyst phillip securities ltd mumbai plant old plant dont think technically important plant sun
indian billionaire dilip shanghvi started sun pharma 1983 selling drugs treat psychiatric illnesses suns shares risen 40 percent past year helping boost shanghvis wealth 136 billion according bloomberg billionaires index
plant makes antibiotic cephalosporin import alert issued fda inspection facility identified noncompliance current good manufacturing practice regulations sun pharma said emailed statement today
company remains fully committed compliance already initiated several corrective steps address observations made us fda said facilitys contribution sun pharmas consolidated revenues negligible according statement company maintained forecast 29 percent sales growth year ending march 2014
cephalosporin facilities usually dedicated production type antibiotic generic antibiotics pretty insignificant contribution suns revenue patra said company focused treatments chronic disease said
sun pharma shares dropped 52 percent 57295 rupees close trading mumbai biggest decline since march 2012
2012 branded drugs represented 2329 billion market us branded unbranded generics accounting another 926 billion according standard chartered
since january 2013 fda added 20 indian drug facilities import alert list including two belonging mumbaibased wockhardt ltd two belonging ranbaxy
fda officials said plan tighten rules regulate genericdrug industry way convince american consumers safeguards place
generic drugs made almost 80 percent 4 billion prescriptions written us 2011 helped americans save 193 billion year generic pharmaceutical association said healthcare costs rise insurers force consumers use
indias pharmaceutical industry exported 146 billion worth products year ended march 2013 according data ministry commerce india secondlargest supplier overthecounter prescription drugs us behind canada
sun pharma ranbaxy separately recalling batches drugs us complaints bottling mixups according fda enforcement report earlier month
sun pharma initiated voluntary recall 2528 bottles diabetes drug metformin hydrochloride customer found gabapentin tablets drug used treat seizures bottle according report
company said october addressed separate concerns raised fda detroitbased manufacturing unit caraco pharmaceutical laboratories ltd fda concerns detailed two socalled form 483s obtained bloomberg via freedom information act request included temperaturecontrol lapses improperly sealed containers deviation qualitycontrol procedures
caraco made 33 drugs us market including common blood pressure pills pain killers june 2009 fda ordered production stopped us marshals seized products made facilities series recalls continued failure meet current good manufacturing practice requirements according fda statement time three years later fda cleared unit sun pharma resume operations two products
